指南与共识肿瘤 PET/CT核素与放射性配体治疗

鲁加诺分类在霍奇金与非霍奇金淋巴瘤初始评估、分期和疗效评价中的应用:PRoLoG共识倡议(第2部分——技术层面)

Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).
指南 / 共识 · J Nucl Med · 2022-07-14

该共识倡议旨在由淋巴瘤与影像领域的学术及产业专家联盟就鲁加诺分类的影像评估一致应用提供共识推荐;共识通过2019年7月至2021年10月间一系列会议达成,涵盖PET/CT与诊断CT的技术方面、影像与临床审核者的角色及培训监测,并提供影像病例报告表模板以支持鲁加诺分类数据的高效采集。

要点

  • 共识推荐涵盖鲁加诺分类的全部技术影像方面。
  • 澄清了PET/CT与诊断CT在所需影像序列、扫描访视及PET图像采集重建方面的技术考量。
  • 提供了影像病例报告表示例模板以支持鲁加诺分类数据的高效采集。

核心结论

  • 共识推荐全面处理终端用户在使用该分类时遇到的技术与影像领域的不一致和模糊之处。
  • 该指导应用于支持鲁加诺2014分类的标准化采集与评估。

研究设计与样本

  • 由淋巴瘤与影像领域学术及产业专家组成的联盟通过2019年7月至2021年10月间一系列会议达成共识,由PINTaD赞助,作为ProLoG共识倡议的一部分。

主要发现

  • 共识推荐涵盖鲁加诺分类的全部技术影像方面。
  • 澄清了PET/CT与诊断CT在所需影像序列与扫描访视以及PET图像采集和重建、病灶大小与背景活性的影响方面的技术考量。
  • 就影像与临床审核者的角色以及培训与监测给出了推荐。
  • 提供了影像病例报告表示例模板以支持鲁加诺分类数据的高效采集。

临床怎么用

  • 该共识推荐用于支持鲁加诺2014分类的标准化采集与评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this initiative was to provide consensus recommendations from a consortium of academic and industry experts in the field of lymphoma and imaging for the consistent application of imaging assessment with the Lugano classification. Methods: Consensus was obtained through a series of meetings from July 2019 to October 2021 sponsored by the PINTaD (Pharma Imaging Network for Therapeutics and Diagnostics) as part of the ProLoG (PINTaD RespOnse criteria in Lymphoma wOrking Group) consensus initiative. Results: Consensus recommendations encompass all technical imaging aspects of the Lugano classification. Some technical considerations for PET/CT and diagnostic CT are clarified with regards to required imaging series and scan visits, as well as acquisition and reconstruction of PET images and influence of lesion size and background activity. Recommendations are given on the role of imaging and clinical reviewers as well as on training and monitoring. Finally, an example template of an imaging case report form is provided to support efficient collection of data with Lugano Classification. Conclusion: Consensus recommendations are made to comprehensively address technical and imaging areas of inconsistency and ambiguity in the classification encountered by end users. Such guidance should be used to support standardized acquisition and evaluation with the Lugano 2014.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Ricard F, Barrington S, Korn R, et al. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical). J Nucl Med. 2022. PMID: 35835581. doi:10.2967/jnumed.122.264124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。